Verona Pharma American Depositary Share Shares Outstanding 2017-2024 | VRNA

Verona Pharma American Depositary Share shares outstanding for the quarter ending September 30, 2024 were 0.081B, a 2.15% increase year-over-year.

  • Verona Pharma American Depositary Share 2023 shares outstanding were 0.079B, a 19.86% increase from 2022.
  • Verona Pharma American Depositary Share 2022 shares outstanding were 0.066B, a 11.81% increase from 2021.
  • Verona Pharma American Depositary Share 2021 shares outstanding were 0.059B, a 79.96% increase from 2020.

Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.

Verona Pharma American Depositary Share Shares Outstanding 2017-2024 | VRNA

  • Verona Pharma American Depositary Share 2023 shares outstanding were 0.079B, a 19.86% increase from 2022.
  • Verona Pharma American Depositary Share 2022 shares outstanding were 0.066B, a 11.81% increase from 2021.
  • Verona Pharma American Depositary Share 2021 shares outstanding were 0.059B, a 79.96% increase from 2020.

Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
Related Stocks
Company NameMarket
Cap
AstraZeneca (AZN)$231.2B
Amgen (AMGN)$160B
Gilead Sciences (GILD)$137.1B
Vertex Pharmaceuticals (VRTX)$123.3B
Bristol Myers Squibb (BMY)$113.2B
CSL (CSLLY)$80.1B
GSK (GSK)$76.6B
Regeneron Pharmaceuticals (REGN)$76.1B
Argenex SE (ARGX)$39.3B
Alnylam Pharmaceuticals (ALNY)$32.5B
BioNTech SE (BNTX)$28.3B
BeiGene (ONC)$23.9B
Biogen (BIIB)$20.1B
Illumina (ILMN)$15.4B
Insmed (INSM)$15B
Genmab (GMAB)$14.9B
Genmab (GNMSF)$14.7B
Incyte (INCY)$13.8B
Intra-Cellular Therapies (ITCI)$13.7B
BioMarin Pharmaceutical (BMRN)$13.1B
Moderna (MRNA)$13B
Swedish Orphan Biovitrum (BIOVF)$10.9B
Sarepta Therapeutics (SRPT)$10.4B
Bio-Techne Corp (TECH)$10.4B
Vaxcyte (PCVX)$10.3B
Exelixis (EXEL)$9.8B
Ascendis Pharma (ASND)$9.4B
Exact Sciences (EXAS)$9.2B
Repligen (RGEN)$9.1B
Bio-Rad Laboratories (BIO.B)$8.7B